Insulia

獲取與Insulia應用個性化的胰島素劑量的建議。

When you have type 2 diabetes, calculating your daily dose of basal insulin can be challenging. Insulia® makes it easier by doing the calculations for you.

Insulia® is an FDA-regulated, prescription-only app that uses clinical algorithms to recommend insulin doses that are tailored to you. Whether you’re just starting on basal insulin or having difficulty getting to your glucose goal, your doctor can prescribe Insulia to get you on the right track.

Your doctor will prescribe the app by creating a treatment plan tailored to your needs, which generates an activation code. When you download the app and enter your code, Insulia is already set up to follow your personalized dosing plan. Just add your fasting blood glucose values and Insulia will recommend your basal insulin doses every day. Whether you take your insulin in the morning or evening, experience hypo symptoms or switch insulins, Insulia adapts to you so that you have accurate and reliable dose recommendations at your fingertips.

Since Insulia connects to a corresponding web portal, your doctor will be able to follow your progress in real-time and help you when needed. Coaching messages and support ensure that you’re never alone as you work to get to the right dose. Insulia is with you. Every day.

Contact your doctor to get an activation code and start using Insulia.

Important Information

Insulia® is a prescription-only software medical device intended for use by healthcare professionals and their type 2 adult diabetes patients treated with long-acting insulin analogs as an aid in the management of diabetes. Insulia® is only indicated for use with insulin detemir (Levemir® U-100) once or twice daily, insulin degludec (Tresiba® U-100) and insulin glargine (Lantus® U-100, Toujeo® U-300 and Basaglar® U-100) once daily. Insulia® should not be used for basal dose recommendations with intermediate-acting insulin (NPH - Neutral Protamine Hagedorn) nor with premixed insulin. Insulia® is not intended for use by pregnant women, non-adult patients or patients that are treated with a basal-plus or a basal-bolus regimen (i.e. including multiple mealtime insulin injections per day or insulin pump therapy).